- Home
- BTM vs ACHL Comparison
BTM vs ACHL Comparison
Compare BTM & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTM
- ACHL
- Stock Information
- Founded
- BTM 2016
- ACHL 2016
- Country
- BTM United States
- ACHL United Kingdom
- Employees
- BTM N/A
- ACHL N/A
- Industry
- BTM Finance: Consumer Services
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BTM Finance
- ACHL Health Care
- Exchange
- BTM Nasdaq
- ACHL Nasdaq
- Market Cap
- BTM 39.1M
- ACHL 43.6M
- IPO Year
- BTM N/A
- ACHL 2021
- Fundamental
- Price
- BTM $1.73
- ACHL $0.98
- Analyst Decision
- BTM Strong Buy
- ACHL Buy
- Analyst Count
- BTM 3
- ACHL 2
- Target Price
- BTM $3.67
- ACHL $4.00
- AVG Volume (30 Days)
- BTM 574.7K
- ACHL 128.2K
- Earning Date
- BTM 11-13-2024
- ACHL 11-14-2024
- Dividend Yield
- BTM N/A
- ACHL N/A
- EPS Growth
- BTM N/A
- ACHL N/A
- EPS
- BTM N/A
- ACHL N/A
- Revenue
- BTM $585,282,000.00
- ACHL N/A
- Revenue This Year
- BTM N/A
- ACHL N/A
- Revenue Next Year
- BTM $7.15
- ACHL N/A
- P/E Ratio
- BTM N/A
- ACHL N/A
- Revenue Growth
- BTM N/A
- ACHL N/A
- 52 Week Low
- BTM $1.33
- ACHL $0.63
- 52 Week High
- BTM $3.70
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- BTM 42.95
- ACHL 36.56
- Support Level
- BTM $1.82
- ACHL $0.92
- Resistance Level
- BTM $2.06
- ACHL $1.01
- Average True Range (ATR)
- BTM 0.15
- ACHL 0.04
- MACD
- BTM -0.02
- ACHL -0.01
- Stochastic Oscillator
- BTM 17.02
- ACHL 37.41
About BTM Bitcoin Depot Inc.
Bitcoin Depot Inc owns and operates the largest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.